Match!
Lilla Reiniger
Semmelweis University
PathologyImmunologyCancer researchMedicineBiology
49Publications
10H-index
320Citations
What is this?
Publications 53
Newest
#1Csaba Bödör (Semmelweis University)H-Index: 17
#2Donát Alpár (Semmelweis University)H-Index: 3
Last. Lilla Reiniger (Semmelweis University)H-Index: 10
view all 22 authors...
Source
#1Ambrus Gángó (Semmelweis University)H-Index: 2
#2Donát Alpár (Semmelweis University)H-Index: 3
Last. Csaba Bödör (Semmelweis University)H-Index: 17
view all 21 authors...
Source
#1Jayendrakishore Tanjore Ramanathan (UH: University of Helsinki)
Last. Pirjo Laakkonen (UH: University of Helsinki)H-Index: 29
view all 11 authors...
Glioblastomas and brain metastases (BM) of solid tumors are the most common central nervous system neoplasms associated with very unfavorable prognosis. In this study, we report the association of Prostate Specific Membrane Antigen with various clinical parameters in a large cohort of primary and secondary brain tumors. A tissue micro array containing 371 cases of ascending grade gliomas pertaining to astrocytic origin, samples of 52 cases of primary lung carcinomas with matching brain metastase...
Source
#1Anna-Mária Tőkés (Semmelweis University)H-Index: 9
#2Orsolya Rusz (University of Szeged)H-Index: 3
Last. Zoltan Szallasi (Semmelweis University)H-Index: 55
view all 14 authors...
Source
#1Judit MoldvayH-Index: 11
#2Vanda TéglásiH-Index: 3
Last. Lilla ReinigerH-Index: 10
view all 14 authors...
Source
#2Judit MoldvayH-Index: 11
Last. Lilla ReinigerH-Index: 10
view all 4 authors...
#1Vanda Téglási (Semmelweis University)H-Index: 3
#2Orsolya Pipek (ELTE: Eötvös Loránd University)H-Index: 6
Last. Lilla Reiniger (Semmelweis University)H-Index: 10
view all 14 authors...
Abstract Background Approximately 50% of brain metastases originate from non–small-cell lung cancer. The median survival of patients with brain metastases is 1 month without treatment. Novel immunotherapeutic strategies, such as those targeting the programmed death ligand 1 (PD-L1)/programmed cell death 1 (PD-1) axis, are promising in patients with advanced systemic disease but are often preferentially administered to patients with tumors showing PD-L1 positivity. Patients and Methods Surgically...
Source
#1Kinga Németh (Semmelweis University)H-Index: 2
#2Ottó Darvasi (Semmelweis University)H-Index: 2
Last. Henriett Butz (Semmelweis University)H-Index: 9
view all 12 authors...
Source
#1Ambrus Gángó (Semmelweis University)H-Index: 2
#2Donát Alpár (Semmelweis University)H-Index: 3
Last. Csaba Bödör (Semmelweis University)H-Index: 17
view all 20 authors...
Source
#1Lilla Reiniger (MTA: Hungarian Academy of Sciences)H-Index: 10
#2Vanda Téglási (Semmelweis University)H-Index: 3
Last. Judit Moldvay (MTA: Hungarian Academy of Sciences)H-Index: 11
view all 14 authors...
AbstractBackground: Predictive biomarkers for immunotherapy in lung cancer are intensively investigated; however, correlations between PD-L1/PD-1 expressions and clinical features or histopathologi...
1 CitationsSource
123456